🔴 Neuronetics is trading 7.16% down in pre-market

Neuronetics is trading 7.16% down in pre-market at $2.70, after falling from its September 14 close of $2.90.

• Searches found no new earnings release, regulatory announcement, or company-specific negative news dated September 15, 2026.
• The only scheduled item is a virtual management meeting with BTIG; B. Riley’s September 11 Buy initiation and $5 price target were earlier positive news.
• Healthcare-sector strength does not explain this company-specific decline.